Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$65.84 -0.41 (-0.62%)
As of: Sep 30, 2026 · 9:49 AM EDT

Arrowhead Pharmaceuticals (ARWR) EV to EBIT (2019 - 2025)

Updated

Arrowhead Pharmaceuticals' (ARWR) EV to EBIT came in at 27.28 for fiscal Q1 2026 (quarter ended Dec 31, 2025), down 29.4% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) EV to EBIT (2019 - 2025) Analysis & Trends

For the trailing twelve months through Dec 31, 2025, EV to EBIT at Arrowhead Pharmaceuticals was 17.57; for FY2025 (ended Sep 30, 2025), it came in at 38.62.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 27.28
Sep 30, 2025 38.62
Mar 31, 2020 2,295.79
Dec 31, 2019 130.22
Sep 30, 2019 39.75
Jun 30, 2019 56.60
Mar 31, 2019 258.75
API Access

Arrowhead Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ARWR&period=max&api_key=YOUR_API_KEY